Cargando…

Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases

Rheumatoid arthritis (RA) is an autoimmune disorder that affects joints and is characterized by synovial hyperplasia and bone erosion associated with neovascularization and infiltration of proinflammatory cells. The introduction of biological disease-modifying anti-rheumatic drugs has dramatically c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Yoshiya, Hoshino-Negishi, Kana, Kuboi, Yoshikazu, Tago, Fumitoshi, Yasuda, Nobuyuki, Imai, Toshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649223/ https://www.ncbi.nlm.nih.gov/pubmed/33178636 http://dx.doi.org/10.2147/ITT.S277991

Ejemplares similares

The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival
por: Kuboi, Yoshikazu, et al.
Publicado: (2022)

Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study
por: Tanaka, Yoshiya, et al.
Publicado: (2021)

Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
por: Imai, Toshio, et al.
Publicado: (2016)

The roles of fractalkine signaling in neurodegenerative disease
por: Lamb, Bruce
Publicado: (2012)

Pathological Role of Fractalkine/CX3CL1 in Rheumatic Diseases: A Unique Chemokine with Multiple Functions
por: Jones, Brian, et al.
Publicado: (2012)

Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity
por: Suzuki, Fumihito, et al.
Publicado: (2012)

Anti-Apoptotic Effects of Recombinant Human Hepatocyte Growth Factor on Hepatocytes Were Associated with Intrahepatic Hemorrhage Suppression Indicated by the Preservation of Prothrombin Time
por: Motoi, Sotaro, et al.
Publicado: (2019)

Neuroinflammation and fractalkine signaling in Alzheimer’s disease
por: Finneran, Dylan J., et al.
Publicado: (2019)

Emergent Role of the Fractalkine Axis in Dissemination of Peritoneal Metastasis from Epithelial Ovarian Carcinoma
por: Main, Hilal Gurler, et al.
Publicado: (2016)

Fractalkine Depresses Cardiomyocyte Contractility
por: Taube, David, et al.
Publicado: (2013)

Role of Fractalkine-CX3CR1 Axis in Acute Rejection of Mouse Heart Allografts Subjected to Ischemia Reperfusion Injury
por: Kanzawa, Taichi, et al.
Publicado: (2022)

The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases?
por: Tanaka, Yoshiya
Publicado: (2019)

Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma
por: Gurler, Hilal, et al.
Publicado: (2015)

The Role of Fractalkine in the Regulation of Endometrial Iron Metabolism in Iron Deficiency
por: Pandur, Edina, et al.
Publicado: (2023)

Correction: Fractalkine Depresses Cardiomyocyte Contractility
por: Taube, David, et al.
Publicado: (2013)

Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases
por: Eugenín, Jaime, et al.
Publicado: (2023)

Altered fractalkine cleavage results in an organ-specific 17 kDa fractalkine fragment in salivary glands of NOD mice
por: Delaleu, Nicolas, et al.
Publicado: (2008)

Fractalkine and CX(3)CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow
por: Fong, Alan M., et al.
Publicado: (1998)

Fractalkine and Other Chemokines in Primary Biliary Cirrhosis
por: Shimoda, Shinji, et al.
Publicado: (2012)

Metalloprotease Dependent Release of Placenta Derived Fractalkine
por: Siwetz, Monika, et al.
Publicado: (2014)

Fractalkine Signaling and Microglia Functions in the Developing Brain
por: Arnoux, Isabelle, et al.
Publicado: (2015)

Fractalkine Modulates Microglia Metabolism in Brain Ischemia
por: Lauro, Clotilde, et al.
Publicado: (2019)

Ligand-competent fractalkine receptor is expressed on exosomes
por: Park, Eun Jeong, et al.
Publicado: (2021)

Modulation of inflammatory responses by fractalkine signaling in microglia
por: Inoue, Koichi, et al.
Publicado: (2021)

Association of CX3CR1 Gene Polymorphisms with Fractalkine, Fractalkine Receptor, and C-Reactive Protein Levels in Patients with Kidney Failure
por: Woźny, Łukasz, et al.
Publicado: (2021)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

Fractalkine regulation of microglial physiology and consequences on the brain and behavior
por: Paolicelli, Rosa Chiara, et al.
Publicado: (2014)

Circulating Fractalkine Levels Predict the Development of the Metabolic Syndrome
por: Xueyao, Yin, et al.
Publicado: (2014)

Fractalkine/CX3CL1 in Neoplastic Processes
por: Korbecki, Jan, et al.
Publicado: (2020)

Leptin and fractalkine: novel subcutaneous cytokines in burn injury
por: Friston, Dominic, et al.
Publicado: (2020)

Fractalkine Is Linked to the Necrosome Pathway in Acute Pulmonary Inflammation
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2021)

Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice
por: Mizutani, Satoshi, et al.
Publicado: (2021)

Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients
por: Hoogendijk, Arie J., et al.
Publicado: (2015)

Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease
por: Thome, Aaron D., et al.
Publicado: (2015)

Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington’s Disease
por: Kim, Anya, et al.
Publicado: (2020)

EHMTI-0062. Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
por: Gazerani, P, et al.
Publicado: (2014)

Fractalkine Signalling (CX(3)CL1/CX(3)CR1 Axis) as an Emerging Target in Coronary Artery Disease
por: Loh, Shu Xian, et al.
Publicado: (2023)

Fractalkine Preferentially Mediates Arrest and Migration of CD16(+) Monocytes
por: Ancuta, Petronela, et al.
Publicado: (2003)

Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress
por: Ślusarczyk, Joanna, et al.
Publicado: (2016)

Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice
por: McMillin, Matthew, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qnocuv51u1o8h0tsgrpiser5ou